Zobrazeno 1 - 10
of 17
pro vyhledávání: '"R V, Pollock"'
Publikováno v:
Journal of the American Veterinary Medical Association. 204(12)
Data were obtained and analyzed for 2,144 pups examined at 65 veterinary hospitals in the northeastern United States to determine whether there were significant differences in the frequency of disease and death among pups acquired from private owners
Publikováno v:
The Cornell veterinarian. 82(2)
The long-term safety of a temperature-sensitive feline infectious peritonitis (FIP) vaccine was evaluated. Five hundred eighty-two healthy cats of various age groups were vaccinated with 2 doses of the vaccine. Seventy-eight percent, or 453 cats, wer
Autor:
J M, Scarlett, R V, Pollock
Publikováno v:
Journal of the American Veterinary Medical Association. 199(10)
A blind randomized field trial of a commercial FeLV vaccine was conducted. Cats on study were vaccinated with either a commercial FeLV vaccine or a placebo, then housed with FeLV-positive cats in a ratio of approximately 2 study cats to 1 infected ca
Autor:
R V, Pollock, J M, Scarlett
Publikováno v:
Journal of the American Veterinary Medical Association. 196(4)
A randomized blind trial of a commercial FeLV vaccine was conducted to evaluate its performance in cats under conditions of long-term natural exposure. Seventy-nine nonviremic, seronegative cats were randomized into 2 groups. Cats were given 3 doses
Publikováno v:
The Cornell veterinarian. 80(1)
Detection of virus in saliva using a commercial enzyme-linked immunosorbent assay (ELISA), ClinEase-VirastatR, was compared to evidence of FeLV infection by the indirect immunofluorescent antibody assay (IFA) and plasma ELISA. The sensitivity and spe
Publikováno v:
Modern veterinary practice. 65(2)
Pups 9-18 1/2 weeks old were given a single dose of 1 of 4 commercial, live, canine-origin parvovirus vaccines. All 4 vaccines evoked high levels of antibody in seronegative pups, but variable response in those with low levels of maternally derived a
Publikováno v:
The Cornell veterinarian. 73(1)
The safety and efficacy of an attenuated canine parvovirus (A-CPV) vaccine was evaluated in both experimental and in field dogs. After parenteral vaccination, seronegative dogs developed hemagglutination-inhibition (HI) antibody titers as early as po
Autor:
R V, Pollock, L E, Carmichael
Publikováno v:
The Cornell veterinarian. 72(1)
Inactivated canine parvovirus (CPV) and inactivated feline panleukopenia virus (FPV) vaccines were evaluated in dogs. Maximal serologic response occurred within 1-2 weeks after vaccination. Antibody titers then declined rapidly to low levels that per
Autor:
R V, Pollock
Publikováno v:
The Veterinary clinics of North America. Small animal practice. 16(4)
The potential of computers to assist veterinarians in medical management is reviewed. It is argued that computers will contribute to improved patient care by solving the information retrieval and processing problems in medicine. Strategies to accompl
Autor:
R V, Pollock, L E, Carmichael
Publikováno v:
Journal of the American Veterinary Medical Association. 180(1)
Antibody to canine parvovirus (CPV) was transferred from an immune bitch to her pups through the placenta and colostrum. Colostral transfer accounted for approximately 90% of the maternally-derived CPV antibody. After suckling, pups and hemagglutinat